Login / Signup

The pathogenesis of microthrombi in COVID-19 cannot be controlled by DOAC: NETosis should be the target.

E GremeseGianfranco Ferraccioli
Published in: Journal of internal medicine (2021)
Keyphrases
  • coronavirus disease
  • sars cov
  • direct oral anticoagulants
  • respiratory syndrome coronavirus
  • venous thromboembolism